BALYASNY ASSET MANAGEMENT L.P. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,559,666
+6.2%
265,037
+21.5%
0.01%
-7.1%
Q2 2023$6,176,592
-16.2%
218,100
-32.1%
0.01%
-22.2%
Q1 2023$7,373,530
-6.1%
321,007
+14.8%
0.02%
-14.3%
Q4 2022$7,849,961
+149.2%
279,557
+210.7%
0.02%
-8.7%
Q3 2020$3,150,000
+993.8%
89,988
+2006.0%
0.02%
+1050.0%
Q1 2019$288,000
-98.3%
4,273
-98.8%
0.00%
-98.3%
Q4 2018$16,728,000
-38.4%
362,776
+3.1%
0.12%
-2.4%
Q3 2018$27,146,000
-46.9%
351,997
-42.0%
0.12%
-47.0%
Q2 2018$51,124,000
-8.5%
606,952
-11.2%
0.23%
-0.4%
Q1 2018$55,886,000
-13.5%
683,364
-39.5%
0.23%
+15.3%
Q4 2017$64,617,000
-21.7%
1,130,263
-8.6%
0.20%
-37.7%
Q3 2017$82,514,000
+68.4%
1,236,152
+29.8%
0.32%
+60.4%
Q2 2017$48,993,000
-3.5%
952,252
+9.6%
0.20%
-14.8%
Q1 2017$50,757,000
+61.1%
869,122
+15.1%
0.24%
+39.4%
Q4 2016$31,509,000
-35.2%
755,082
-18.0%
0.17%
-39.5%
Q3 2016$48,632,000
+256.5%
920,704
+182.8%
0.28%
+219.3%
Q2 2016$13,640,000
+241.3%
325,570
+230.7%
0.09%
+266.7%
Q1 2016$3,997,000
-29.6%
98,450
+12.5%
0.02%
-38.5%
Q4 2015$5,681,000
-36.2%
87,500
-30.6%
0.04%
-40.9%
Q3 2015$8,906,000126,1610.07%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders